AU739385B2 - Condensed thiophene compounds and pharmaceutical use thereof - Google Patents

Condensed thiophene compounds and pharmaceutical use thereof Download PDF

Info

Publication number
AU739385B2
AU739385B2 AU88890/98A AU8889098A AU739385B2 AU 739385 B2 AU739385 B2 AU 739385B2 AU 88890/98 A AU88890/98 A AU 88890/98A AU 8889098 A AU8889098 A AU 8889098A AU 739385 B2 AU739385 B2 AU 739385B2
Authority
AU
Australia
Prior art keywords
formula
benzothieno
alkyl
methylpiperazin
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU88890/98A
Other languages
English (en)
Other versions
AU8889098A (en
Inventor
Masatake Fujimura
Kenji Hashimoto
Hideki Horiuchi
Koreichi Kimura
Toshiyuki Kohara
Koji Seio
Hiroshi Tanaka
Hiroshi Yasumatsu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tanabe Pharma Corp
Original Assignee
Welfide Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27322564&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AU739385(B2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Welfide Corp filed Critical Welfide Corp
Publication of AU8889098A publication Critical patent/AU8889098A/en
Assigned to WELFIDE CORPORATION reassignment WELFIDE CORPORATION Amend patent request/document other than specification (104) Assignors: YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD.
Application granted granted Critical
Publication of AU739385B2 publication Critical patent/AU739385B2/en
Assigned to MITSUBISHI PHARMA CORPORATION reassignment MITSUBISHI PHARMA CORPORATION Request to Amend Deed and Register Assignors: WELFIDE CORPORATION
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
AU88890/98A 1997-09-02 1998-08-31 Condensed thiophene compounds and pharmaceutical use thereof Ceased AU739385B2 (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
JP23670097 1997-09-02
JP9-236700 1997-09-02
JP27777197 1997-10-09
JP9-277771 1997-10-09
JP10-165725 1998-06-12
JP16572598 1998-06-12
PCT/JP1998/003915 WO1999011647A1 (en) 1997-09-02 1998-08-31 Fused thiophene compounds and medicinal use thereof

Publications (2)

Publication Number Publication Date
AU8889098A AU8889098A (en) 1999-03-22
AU739385B2 true AU739385B2 (en) 2001-10-11

Family

ID=27322564

Family Applications (1)

Application Number Title Priority Date Filing Date
AU88890/98A Ceased AU739385B2 (en) 1997-09-02 1998-08-31 Condensed thiophene compounds and pharmaceutical use thereof

Country Status (16)

Country Link
US (2) US6271225B1 (cg-RX-API-DMAC7.html)
EP (1) EP1016664B1 (cg-RX-API-DMAC7.html)
JP (2) JP3156933B2 (cg-RX-API-DMAC7.html)
KR (1) KR20010021989A (cg-RX-API-DMAC7.html)
CN (1) CN1268949A (cg-RX-API-DMAC7.html)
AT (1) ATE244245T1 (cg-RX-API-DMAC7.html)
AU (1) AU739385B2 (cg-RX-API-DMAC7.html)
BR (1) BR9814042A (cg-RX-API-DMAC7.html)
CA (1) CA2302409A1 (cg-RX-API-DMAC7.html)
DE (1) DE69816102D1 (cg-RX-API-DMAC7.html)
HU (1) HUP0003718A3 (cg-RX-API-DMAC7.html)
IL (1) IL134812A0 (cg-RX-API-DMAC7.html)
NO (1) NO20001049L (cg-RX-API-DMAC7.html)
NZ (1) NZ503484A (cg-RX-API-DMAC7.html)
RU (1) RU2197491C2 (cg-RX-API-DMAC7.html)
WO (1) WO1999011647A1 (cg-RX-API-DMAC7.html)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6590083B1 (en) 1999-04-16 2003-07-08 Ortho-Mcneil Pharmaceutical, Inc. Ketolide antibacterials
US6399582B1 (en) 1999-04-16 2002-06-04 Ortho-Mcneil Pharmaceutical, Inc. Ketolide antibacterials
US6608053B2 (en) * 2000-04-27 2003-08-19 Yamanouchi Pharmaceutical Co., Ltd. Fused heteroaryl derivatives
US6751036B2 (en) * 2000-08-04 2004-06-15 Seagate Technology Llc Tuning track density for data storage device
US8329924B2 (en) * 2001-06-11 2012-12-11 Vertex Pharmaceuticals (Canada) Incorporated Compounds and methods for the treatment or prevention of Flavivirus infections
EP2363396A1 (en) * 2001-06-11 2011-09-07 Virochem Pharma Inc. Thiophene derivatives as antiviral agents for flavivirus infection
ES2285227T3 (es) 2002-08-05 2007-11-16 Eli Lilly And Company Arilbenzodiazepinas sustituidas con piperazina.
DE60332482D1 (de) 2002-12-10 2010-06-17 Virochem Pharma Inc Verbindungen und methoden zum behandeln oder vorbeugen von flavivirus infektionen
US20040236181A1 (en) * 2003-04-01 2004-11-25 Olympus Corporation In-body information acquiring apparatus and power-supply circuit
CA2536107A1 (en) * 2003-09-09 2005-03-24 Eli Lilly And Company Substituted piperazines of azepines, oxazepines, and thiazepines
RU2248205C1 (ru) * 2003-09-18 2005-03-20 Открытое акционерное общество "Щелковский витаминный завод" Лекарственное средство в виде желатиновой капсулы
EP1713486A4 (en) * 2003-12-02 2009-04-29 Sheldon Leslie James COMBINED THERAPY FOR THE TREATMENT OF DEMENTIA, DEPRESSION AND APATHY
WO2005063771A1 (en) * 2003-12-22 2005-07-14 Teva Pharmaceutical Industries Ltd Methods of preparing olanzapine
US7807828B2 (en) * 2005-08-11 2010-10-05 Hypnion, Inc. Olanzapine analogs and methods of use thereof
SG176488A1 (en) * 2006-11-15 2011-12-29 Virochem Pharma Inc Thiophene analogues for the treatment or prevention of flavivirus infections
PL395468A1 (pl) 2011-06-29 2013-01-07 Adamed Spólka Z Ograniczona Odpowiedzialnoscia Zwiazki amidoalkilopiperazynylowe do leczenia chorób osrodkowego ukladu nerwowego
JP6551671B2 (ja) * 2015-08-11 2019-07-31 国立大学法人 熊本大学 アルツハイマー治療薬
US12365696B2 (en) 2019-05-10 2025-07-22 Dana-Farber Cancer Institute, Inc. Small-molecule focal adhesion kinase (FAK) inhibitors

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL140242B (nl) 1963-03-01 1973-11-15 Wander Ag Dr A Werkwijze voor het bereiden van op de 11-plaats door een basische groep gesubstitueerde dibenz (b.f.)(1.4) oxazepinen.
CH468400A (de) 1965-12-23 1969-02-15 Sandoz Ag Verfahren zur Herstellung neuer Thieno(2,3-b)(1,5)benzothiazepin-4-on-Verbindungen
US3683084A (en) 1969-02-06 1972-08-08 Jean Schmutz Basically substituted heterocycles as anti-emetics
US3726977A (en) 1969-02-06 1973-04-10 Sandoz Ag 2-NITRO-11-(1-PIPERAZINYL)-DIBENZ (b,f) (1,4) OXAZEPINES COMPOSITIONS IN THE TREATMENT OF DEPRESSION
US3962248A (en) * 1972-04-04 1976-06-08 Sandoz, Inc. Process for making 11-piperazino-diazepines, oxazepines, thiazepines and azepines
SU629879A3 (ru) * 1974-11-26 1978-10-25 Лилли Индастриз Лимитед, (Фирма) Способ получени тиено(1,5) бензодиазепинов или их солей
US4115568A (en) 1974-11-26 1978-09-19 Lilly Industries Limited Thieno[3,2-b]-[1,5]benzodiazepines
US4172831A (en) 1974-11-26 1979-10-30 Lilly Industries Limited Thieno-benzodiazepines
GB1533236A (en) * 1975-11-24 1978-11-22 Lilly Industries Ltd Thieno(1,5)benzodiazepine intermediates
US4157444A (en) 1978-03-13 1979-06-05 American Cyanamid Company 10-(Piperazinyl)thieno[3,4-b][1,5]benzoxazepines and 10-(piperazinyl)thieno[3,4-b][1,5]benzothiazepines
GB9009229D0 (en) 1990-04-25 1990-06-20 Lilly Industries Ltd Pharmaceutical compounds
US5538965A (en) 1993-12-23 1996-07-23 Allelix Biopharmaceuticals Inc. Dopamine receptor ligands
US5602121A (en) 1994-12-12 1997-02-11 Allelix Biopharmaceuticals, Inc. Alkyl-substituted compounds having dopamine receptor affinity
US5700445A (en) 1994-12-12 1997-12-23 Allelix Biopharmaceuticals, Inc. N-methyl piperazine compounds having dopamine receptor affinity
US5602124A (en) 1994-12-12 1997-02-11 Allelix Biopharmaceuticals, Inc. 5-HT2 receptor ligands
US5576314A (en) 1994-12-12 1996-11-19 Allelix Biopharmaceuticals Inc. Bicyclic nonane and decane compounds having dopamine receptor affinity
US5602120A (en) 1994-12-12 1997-02-11 Allelix Biopharmaceuticals, Inc. Benzyl-substituted compounds having dopamine receptor affinity
US5561127A (en) 1994-12-19 1996-10-01 Allelix Biopharmaceuticals, Inc. Muscarinic receptor ligands

Also Published As

Publication number Publication date
US6271225B1 (en) 2001-08-07
DE69816102D1 (de) 2003-08-07
NZ503484A (en) 2001-10-26
ATE244245T1 (de) 2003-07-15
IL134812A0 (en) 2001-04-30
NO20001049L (no) 2000-04-03
HUP0003718A3 (en) 2002-11-28
NO20001049D0 (no) 2000-03-01
JP3156933B2 (ja) 2001-04-16
KR20010021989A (ko) 2001-03-15
EP1016664A1 (en) 2000-07-05
HUP0003718A2 (hu) 2001-09-28
US20020042411A1 (en) 2002-04-11
EP1016664B1 (en) 2003-07-02
CN1268949A (zh) 2000-10-04
CA2302409A1 (en) 1999-03-11
WO1999011647A1 (en) 1999-03-11
RU2197491C2 (ru) 2003-01-27
JP2001072684A (ja) 2001-03-21
AU8889098A (en) 1999-03-22
US6455521B1 (en) 2002-09-24
EP1016664A4 (en) 2001-01-24
BR9814042A (pt) 2000-10-03
JP4354106B2 (ja) 2009-10-28

Similar Documents

Publication Publication Date Title
US6271225B1 (en) Fused thiophene compounds and medicinal use thereof
JP3239364B2 (ja) 骨粗鬆症治療薬およびジアゼピン化合物
JPH09291034A (ja) 縮合ピリジン化合物およびその医薬としての用途
US20040138230A1 (en) Heterocyclic substituted piperazines for the treatment of schizophrenia
US20100190772A1 (en) Substituted Azepine Derivatives As Serotonin Receptor Modulators
JPWO1999011647A1 (ja) 縮合チオフェン化合物およびその医薬用途
AU2005315914A1 (en) Bi- and tricyclic substituted phenyl methanones as glycine transporter I (GlyT-1) inhibitors for the treatment of Alzheimer's disease
SI9400091A (en) Substituted pyrrolo(2,3-b)pyridine derivatives
CZ194994A3 (en) Piperazine and piperidine derivatives, process of their preparation and pharmaceutical compositions containing thereof
US5130313A (en) Serotonin antagonists, their preparation and medications containing them
WO1997003986A1 (en) Fused triazole compounds
CS236753B2 (en) Processing of thieno (1,5) benzodiazepine derivatives
JP2007505106A (ja) アゼピン、オキサゼピン、およびチアゼピンの置換ピペラジン
KR20010022658A (ko) 3-치환된 3,4,5,7-테트라히드로-피롤로[3'4':4,5]티에노[2,3-d]피리미딘 유도체, 그의 제법 및 5ht길항제로서의 용도
CN120435469A (zh) Ahr激动剂
US6288075B1 (en) Thiazolo[5,4,3-ij]quinolines, preparation and medicines containing the same
HK1029340A (en) Fused thiophene compounds and medicinal use thereof
JPH03279386A (ja) チオフェン化合物、その医薬用途およびその合成中間体
MXPA00002221A (en) Fused thiophene compounds and medicinal use thereof
CZ2000757A3 (cs) Kondenzované thiofenové sloučeniny a jejich farmaceutické použití
JP4436460B2 (ja) チアゾロベンゾ複素環、それらの製造及びそれらを含有する医薬
NO860933L (no) Benzo(c)-1,5-naftyridiner og fremgangsmaate til fremstillling derav.
GB1577743A (en) Benzodiazepine derivatives
JPWO1997003986A1 (ja) 縮合トリアゾール化合物
JPWO1997032848A1 (ja) 縮合へテロ環化合物およびその医薬用途

Legal Events

Date Code Title Description
TC Change of applicant's name (sec. 104)

Owner name: WELFIDE CORPORATION

Free format text: FORMER NAME: YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD.

FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired